U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455903) titled 'Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT' on March 03.
Brief Summary: The purpose of this research study is to test the efficacy of ADT on prostate-specific membrane antigen (PSMA), a marker of prostate cancer, before and after scheduled ADT. Follow up will be 48 months your prostate removal to do a blood test and log if any new or worsening symptoms have occurred as a part of your standard-of-care (SOC).
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Localized Prostate Carcinoma
Intervention:
DRUG: Leuprol...